pregnancy, ectopic pregnancy, suspension because bleeding and other causes, and other adverse events by using either LNG-IUS, etonogestrel Implants, levonorgestrel implants or copper T (last-two included in health care plan). Effectiveness, adverse events and adherence were taken from previously published studies and the costs were taken from database of patients in Colombia and are expressed in Colombian pesos (COP). An expert gynecologist reviewed data. Threshold was estimated in $6.823.583 by calculating the costs assigned by the public health care system in Colombia to health care during the first five years of life of children and cost of delivery care. A sensitivity analysis was developed using a Montecarlo simulation and a Tornado analysis. RESULTS: TOTAL OF 13.87 pregnancies occurred with using LNG-IUS as compared with 40.39 using Copper T, 30.08 using etonorgestrel implant, and 29.55 using levonorgestrel implant for the base case analyzed. Cost of LNG-IUS arm was COP$ 633,747,545 compared with copper T (COP$ 456,638,680), the less expensive. Applying a discount rate of 3% LNG-SIU was dominant versus implant etonogestrel and very cost-effective compared with levonorgestrel implant (ICER $631,682.98) and cost-effective compared with Copper T (ICER COP$ 6,678,395.53). Sensitivity analyses confirm that LNG-UIS keeps its benefits against etonogestrel and levonorgestrel in most cases. CONCLUSIONS: The use of LNG-IUS would be an adequate option for patients seeking a long-acting contraceptive method and its use could be envisaged by the health-care system due to its cost-benefits in Colombia.
PIH30 COST MINIMIZATION COMPARISON OF DARUNAVIR + RITONAVIR (DRV+RTV) TO LOPINAVIR/RITONAVIR (LPV/R) IN HIV-1 INFECTED TREATMENT-NAÏVE WOMEN OF CHILD BEARING AGE (WOCBA)
Desai K 1 , Moller J 2 , Simpson KN 3 , Baran RW 4 , Van de Steen O 5 , Dietz B 6 , Gooch K 4 1 United BioSource Corporation, London, UK, 2 United BioSource Corporation, Eslov, Sweden, 3 Medical University of South Carolina, Charleston, SC, USA, 4 Abbott Laboratories, Abbott Park, IL, USA, 5 Abbott Laboratories, Wavre, IL, Belgium, 6 Abbott GmbH & Co. KG, Ludwigshafen, Germany OBJECTIVES: HIV guidelines consider LPV/r a preferred protease inhibitor for use during pregnancy. The budget implications of proactively initiating LPV/r versus initiating DRV+RTV and then potentially switching to LPV/r upon pregnancy were examined. METHODS: A cost minimization analysis was performed (US health care perspective) for HIV-1 infected, treatment-naïve WOCBA comparing: initiating LPV/r versus initiating DRV+RTV and switching to LPV/r when pregnant. A discrete event simulation was employed to represent antiretroviral (ARV) therapy management. Clinical trial data were used to model pregnancy rates, ARV switch rates, treatment impact as a function of CD4-cell count/viral load, adherence, treatment response, acquired resistance mutations, and treatment changes. Five-and 10-year costs incurred due to ARV therapy, clinical management of AIDS-related, non-AIDS related, and cardiovascular events were estimated. Analysis assumptions: switching to LPV/r can occur only once at first pregnancy, women's medication adherence improves 15% at pregnancy and to 100% if viral rebound. Analyses varied the rate of switching to LPV/r at time of pregnancy (0%, 30%, 100%), pregnancy rates, adherence improvement, and health care costs. Daily drug cost (WAC): LPV/r + TDF/FTC, $56.59; DRV+RTV+TDF/FTC, $73.89. Costs were discounted 3% per annum. RESULTS: With 0% switch, survival was similar for LPV/r and DRV+RTV, 7.68 and 7.69 life years, respectively (+/-0.03 QALYs) at 10 years. Five-and 10-year health care costs of ARV-naïve WOCBA who initiate LPV/r were $107, 790 and $192,352 per patient, respectively, versus $132,694 and $235,854 when initiating DRV+RTV (a $43,502 per patient savings at 10 years). If 100% of patients who initiated DRV+RTV switched to LPV/r upon pregnancy, savings per patient were reduced 21.3%. Sensitivity analyses showed that initiating LPV/r was always cost-saving relative to DRV+RTV. CONCLUSIONS: Initiating HIV infected, treatment-naïve WOCBA on LPV/r was cost saving compared to initiating DRV+RTV. Analysis limitations include the uncertainty of long-term outcomes projections driven by short-term clinical trial endpoints.
PIH31

COST OF FAILED LABOR INDUCTION: A US HOSPITAL PERSPECTIVE
Nicholson G 1 , Cyr PL 2 1 PriceSpective LLC, El Segundo, CA, USA, 2 PriceSpective LLC, Cambridge, MA, USA OBJECTIVES: Labor induction has increasingly been used in the management of obstetrical care, owed to post-term pregnancies, maternal/fetal complications and voluntary election. Several cervical ripening and induction agents are available, though failure or complications with administration of current agents are common. Induction failure generally necessitates either additional induction agents and/or an eventual cesarean section. This analysis descriptively quantifies the economic burden associated with failed medical inductions among US Commercial and Medicaid patients. METHODS: A retrospective analysis of inpatient hospital discharge data for 2010, using the Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS) was performed, to identify delivery stays with primary or secondary diagnoses of failed medical induction (ICD9 659.10-659.13). Rates of cesarean and vaginal delivery, average medical charges (converted to costs and displayed in 2010 USD) and length of stay per patient are provided. RESULTS: Failed labor induction discharges totaled 41,600 in 2010. The average cost for a vaginal delivery (with or without complications) after failed induction was $5,890 (average charges of $17,645) this is compared to average cost of $3,860 (average charges of $10,106) for all vaginal deliveries. Hospital cost for cesareans after failed induction averaged $7,595 (average charges of $28,700) compared to $5,990 (average charges of $21,875) for all cesarean sections. Average length of stay for failed induction with cesarean was 4.42, compared to 3.8 days with vaginal deliveries post-induction failure. CONCLUSIONS: Failed medical induction is associated with increased risk of cesarean delivery, and associated increased hospital resource use, and expenditure in delivery. Preventing complications with induction may substantially reduce health care costs and resource utilization.
INDIVIDUAL'S HEALTH -Patient-Reported Outcomes & Patient Preference Studies
PIH32 VARIATION IN COST-RELATED MEDICATION NON-COMPLIANCE WITH FUNCTIONAL DEFICIENCY AND FREQUENCY OF HOSPITALIZATION AMONG US ELDERLY
Meltzer D 1 , Zhang J 2 1 University of Chicago, Chicago, IL, USA, 2 The University of Chicago, Chicago, IL, USA OBJECTIVES: Cost-related medication non-compliance (CRN) is a persistent issue that negatively impacts the effectiveness of medical intervention. This study aims to evaluate the variation of CRN with functional deficiencies and with frequency of hospitalization among the US elderly using a nationally representative data set. METHODS: Health Retirement Survey (HRS) 2010 was used to assess CRN, deficiencies in Activities of Daily Living (ADL), Instrumental Activities of Daily Life (IADL), and frequency of hospitalization over the past 2 years (0, 1, 2, 3, or 4 or more). CRN was assessed based upon self-reported noncompliance. After performing bivariate analyses of the association between ADLs/IADLs, hospitalizations, insurance coverage, self-reported monthly out-ofpocket (OOP) payments of prescription drugs and CRN, a logit model was used to assess the relationship between CRN and associated risk factors. RESULTS: 2,793 (12.7%) out of 22,042 elderly reported CRN over a period of 2 years. Those reported CRN has a mean ADL deficiencies 0.79 (s.d. 1.43) versus those who did not 0.48 (s.d. 1.16) (p<0.001), and a mean IADL deficiencies 0.53 (s.d. 0.97) versus those who did not 0.38 (s.d. 0.92) (p<0.001). The logit model showed that compared to those who did not have hospitalization, those who had 1 admission were 17% more likely to report CRN (p=0.005), those with 2 admissions 14% more likely (p=0.10), 3 admissions 54% more likely (p<0.001), and 4 or more admissions 33% more likely to report CRN (p=0.007). There was an inverse U-shaped relationship between CRN and deficiencies in ADLs/IADLs; as ADL/IADL deficiencies increased, the likelihood of CRN first increased and then decreased. CONCLUSIONS: The positive relationship between number of hospitalization and CRN and the inverse U-shaped relationship between functional deficiencies and CRN raise concerns that CRN may decrease the effectiveness and increase the cost of care in this population.
PIH33 HEALTH STATE UTILITIES VALUES FOR POST-MENOPAUSAL WOMEN FROM THE WOMEN'S HEALTH INITIATIVE ESTROGEN+PROGESTIN CLINCIAL TRIAL
those included in the 1-year and change analyses completed the SF-36 within 30days of their 1-year follow-up date. RESULTS: All patients contributed to the baseline analysis, and approximately 47% contributed to the 1-year and change analyses. At baseline, mean SF-6D values for all patients 50-59, 60-69, and 70-79 were 0.744 (SD=0.113), 0.743 (SD=0.105), and 0.722 (SD=0.101), respectively. At 1year, E+P arm mean values were 0.754 (SD=0.117), 0.751 (SD=0.117), and 0.725 (SD=0.109), and placebo arm mean values were 0.751 (SD=0.122), 0.748 (SD=0.109), and 0.716 (SD=0.106), respectively. The E+P arm mean changes were -0.008 (SD=0.106), -0.004 (SD=0.096), and 0.000 (SD=0.093), and the placebo arm mean changes were 0.000 (SD=0.105), -0.003 (SD=0.095), and 0.011 (SD=0.093), respectively. CONCLUSIONS: We found minimally decreasing utilities among older age groups, and little variability between utilities by hormone replacement therapy use. These results may be particularly useful in future health economic evaluations of aging women given that they are derived from a large randomized sample, and age group specific. However, our findings may be limited by the homogeneity and representativeness of the E+P trial participants. OBJECTIVES: National health care policy in Brazil is delivered via a two-tiered (public/private) system. Controversy exists since access to private insurance is skewed towards those with higher socioeconomic status, with 75% having incomes >5x the minimum wage, and 95% living in urban areas, mainly in the South and Southeast regions. Our objective was to assess the impact on health status, productivity and health care utilization due to insurance type among patients residing in different regions of Brazil. METHODS: Data were analyzed from the 2011 National Health and Wellness Survey, a nation-wide survey of adults in Brazil (N=12,000). Health status (SF-12v2), work productivity loss (WPAI), and health care resource use within a six-month time frame were compared across individuals in different insurance type strata (i.e., public/private). Data were also stratified according to Brazilian regions comprising the Mid-West, North, Northeast, South and Southeast, and the Federal District. Statistics included unpaired Student-t and Chi-square tests. ANOVA was used to test differences among regions of Brazil. RESULTS: A total 11,985 individuals comprised the public (N=6,074) and private (N=5,911) insurance assessment. Health care utilization was significantly lower among individuals with private insurance (physician consultations: 70.9% versus 86.0%; emergency room visits: 19.6% versus 25.7%; and hospitalizations: 8.9% versus 11.0%; all p<0.05). Overall work impairment (i.e., absenteeism and presenteeism combined) was also significantly lower in the private insurance group (difference=2.8%, 95%CI=1.3%-4.3%). Mental SF-12 score favored those with private insurance (difference=0.058, 95%CI=0.022-0.095), whereas physical SF-12 score favored those with the public insurance (difference=0.062, 95%CI=0.035-0.088). Mid-West and Northern regions reported significantly poorer results than the Southern in almost all assessed parameters. CONCLUSIONS: Individuals covered with private insurance reported both lower health care utilization and work productivity loss. Variable results were reported for health status. Future research should examine the relationship in access/quality between public and private health care services and regions in Brazil. 
PIH34 THE IMPACT OF PRIVATE VERSUS PUBLIC INSURANCE ON HEALTH STATUS, WORK PRODUCTIVITY AND HEALTH CARE UTILIZATION FOR INDIVIDUALS RESIDING IN BRAZIL
PIH35 THE EXPERIENCE OF CARING FOR CHILDREN WITH HEMOPHILIA: CROSS-SECTIONAL STUDY OF CAREGIVERS IN THE UNITED STATES
OBJECTIVES:
Hemophilia is a bleeding disorder resulting from reduced or absent clotting factors. Inhibitors are alloantibodies that develop in response to replacement therapy with coagulation factor products. Patients are diagnosed at birth or shortly thereafter, and care is typically provided at home by parents and relatives (i.e., caregivers). Few formal studies have explored the experience of caregivers of children with hemophilia. This study aimed to quantify the overall burden of hemophilia on caregivers using a novel questionnaire. METHODS: A questionnaire with six domains (emotional stress, financial, sacrifice, medical management, child's pain, and transportation) and several visual analogue scales (VAS) was developed based upon the peer-reviewed literature and previous survey findings. Survey questions were validated with 3 caregivers. Previously developed opt-in research database was used for recruitment. IRB approval was obtained. RESULTS: A total of 310 caregivers (out of 681 invitees) completed the survey. Most respondents were mothers (88%) between 18-54 years. 89% had at least some college education. "Child's pain" was the most burdensome domain (mean score=3.54 out of 5), followed by "emotional stress" (2.79), "financial" (2.52), "transportation" (2.51), "sacrifice" (2.22) and "medical management" (2.05). Caregivers of inhibitor patients had higher total burden scores (96.17 vs. 78.65, p<0.0001) and burden VAS scores (5.57 vs. 3.44, p<0.0001) compared to those without inhibitors. Similar trends were seen for those diagnosed with hemophilia ≤2 years ago versus all else (86.36 vs. 79.83, p<0.04; burden VAS 4.89 vs. 3.47, p<0.0002). Other factors significantly impacting burden were: income ≤ $50,000, taking ≥ 6 hours off work or having >1 bleed in past month (p<0.001). CONCLUSIONS: Hemophilia caregivers are largely impacted by the burden of their child's pain and emotional stress. Since caregivers of patients with inhibitors and those with ≤2 years since diagnosis were more significantly burdened, potential programs can be developed to lessen their burden.
PIH36 PSYCHOMETRIC DEVELOPMENT OF A NEW PRO INSTRUMENT: THE FACE-Q SCALES FOR FACELIFT PATIENTS
Cano S 1 , Pusic A 2 , Scott A 2 , Klassen A 3 1 ScaleReport, Stotfold, UK, New York, NY, USA, 3 McMaster University, Hamilton, ON, Canada OBJECTIVES: Improved satisfaction with facial appearance is the primary desired outcome for patients undergoing facelift procedures. The FACE-Q is a new patient-reported outcome (PRO) instrument composed of scales to evaluate a range of outcomes (appearance concerns, quality of life, adverse effects) for patients undergoing any type of facial cosmetic surgery, minimally invasive cosmetic procedure or facial injectable. The objective of this study was to describe the development and psychometric properties of a set of FACE-Q scales relevant to measuring outcomes in facelift patients. METHODS: The FACE-Q was developed according to international guidelines for PRO instrument development. Scales relevant to facelift patients include five appearance scales (each with five items) covering the following facial areas: cheeks, lower face and jawline, nasolabial folds, area under the chin, and neck. In addition, an adverse effects checklist was developed to measure postoperative symptoms and complications. Data were collected in a larger study that included 225 facelift patients (all had surgery within the past 5 years) between June 2010 and June 2012 (response rate 78%). Rasch measurement theory (RMT) analyses was used to examine clinical meaning, thresholds for item responses, item fit, item locations, differential item functioning (DIF), standardized residuals, and person separation index (PSI). RESULTS: Participants were aged 36 to 77 years and 205 were female. The five appearance scales were found to be clinically meaningful, reliable, valid and responsive to clinical change. Specifically, RMT findings were as follows: no disordered thresholds; overall and individual item fit statistics (29/30 items -2.5/+2.5); no DIF by gender, age or ethnicity; PSI > 0.88 (0.88-0.90). Cronbach's alpha were all >0.94 (0.94-0.97). CONCLUSIONS: The FACE-Q scales for facelift patients are scientifically sound and clinically meaningful scales that may be used to measure the impact of facelift surgery on patient satisfaction. 
PIH37 EXAMINATION OF UNIVERSITY STUDENTS' INTENTION TO UTILIZE EMERGENCY CONTRACEPTION USING THE THEORY OF PLANNED BEHAVIOR
OBJECTIVES:
To use the Theory of Planned Behavior (TPB) to predict university students' intention to use emergency contraception (EC). METHODS: A webbased survey was pretested and emailed to 2,000 university students in May 2010. The web-based survey measured the essential components of the Theory of Planned Behavior: intention, attitude (A), subjective norm (SN), and perceived behavioral control (PBC). The independent variables, A, SN, and PBC, were measured directly as well as by belief-based (indirect) measures. In addition, a measure of recent past behavior was evaluated. RESULTS: An overall usable response rate of 21.0% was obtained. In general, university students intended to use EC should the need occur, held favorable attitudes toward the use of EC, were somewhat influenced by social norms regarding EC use, and perceived themselves to have some control over EC utilization. For direct measures (TPB), A, SN, and PBC were significant predictors of intention to use EC. The direct model explained 49.2 percent of the variance in intention. Using indirect measures, A and SN were significant predictors of intention, but PBC was not; the indirect model accounted for 41.3% of the variance in intention to take EC. Attitude was the strongest TPB predictor for both models, followed by SN and PBC. The RPB variable did not significantly improve the TPB model. CONCLUSIONS: In summary, this study identified several key factors that partially explain why university students either intend or do not intend to use EC if needed. The TPB has utility in predicting utilization of EC in university students. Focusing particular attention on A, as well as SN and PBC, will allow researchers, educators, health care professionals, and legislators to develop strategies and educational programs to enable men and women to use EC responsibly.
PIH39 DEVELOPMENT AND CONTENT VALIDITY OF AN ENDOMETRIOSIS PAIN DAILY DIARY
van Nooten FE 1 , Paty JA 2 , Elash CA 2 , Turner-Bowker DM 2 , Meyers OI 2 , Holtkamp GM 3 , Wilken S 3 , Boerrigter P 3 , Holmstrom S 4 1 Astellas, Leiden, The Netherlands, 2 ERT, Pittsburgh, PA, USA, 3 Astellas Pharma Europe BV, Leiden, The Netherlands, 4 Astellas Pharma Global Development, Leiden, The Netherlands OBJECTIVES: To demonstrate how patient interviews reinforce a conceptual model of endometriosis symptoms and impact and help to identify concepts for inclusion in an improved Endometriosis Pain Daily Diary (EPDD). METHODS: Concept elicitation (CE) interviews were conducted with 17 surgically diagnosed endometriosis patients in the US to identify the PRO measurement concepts related to symptoms and impacts of endometriosis-related pain most important and relevant to patients' experience of endometriosis. Items were developed based on the Endometriosis Pain and Bleeding Diary (EPBD) and existing conceptual data. Cognitive interviews (CI) were conducted with 14 patients in the US to confirm comprehension of the draft items and ability to respond to the items as intended. RESULTS: Based on both spontaneous mentions and the frequency with which concepts were expressed during the CE interviews,
